Cervicovaginal Microbial–Immune State and Group B Streptococcus Colonization in Pregnancy

Abstract

Objective Maternal colonization with Group B Streptococcus (GBS) is a significant risk factor for serious neonatal morbidity. There are limited data on how the cervicovaginal (CV) microbiota and host immune factor β-defensin-2 might influence GBS colonization in pregnant individuals. This study sought to determine if the CV microbiota is associated with GBS colonization in pregnant individuals, and if β-defensin-2 modifies this relationship.

Study Design This was a secondary analysis of a prospective cohort study of pregnant individuals with singleton pregnancies who had CV microbiota specimens analyzed at 16 to 20, 20 to 24, and 24 to 28 weeks' gestation, along with a third trimester GBS rectovaginal (RV) culture (n = 492). Microbiota data were analyzed with 16S rRNA gene sequencing and classified into community state types (CSTs). Log-binomial multivariable regression was used to model associations between CST and GBS RV status and to calculate risk ratios. β-defensin-2, an immune factor known to modulate the relationship between CST and pregnancy outcomes, was examined as an effect modifier.

Results Of 492 individuals, 34.3% were GBS RV + . Compared with individuals with CST I at 16 to 20 weeks, individuals with CST IV-A and CST II had a significantly elevated relative risk of subsequent GBS RV+ status. When stratified by high and low β-defensin-2 levels, β-defensin-2 was found to be an effect modifier of the association between CST IV-A and GBS RV+ status. In individuals with low β-defensin-2 levels, CST VI-A was associated with GBS RV+ status, but among individuals with high β-defensin-2 levels, there was no such association (interaction p-value = 0.03).

Conclusion Pregnant individuals with CV microbiota characterized by CST IV-A and CST II had significantly elevated risk of GBS RV colonization in the third trimester compared with those with CST I, and β-defensin-2 was an effect modifier of the association between CST IV-A and GBS RV+ status. Future research should investigate if manipulation of the CV microbiota can prevent GBS colonization, thereby reducing intrapartum antibiotic prophylaxis and the risks of neonatal GBS infection.

Key Points

• The relationship between the CV microbiota and GBS RV colonization is unknown.

• A Lactobacillus-deficient, anaerobic rich vaginal community, CST IV-A, is associated with increased risk of GBS RV colonization.

• β-defensin-2 is an effect modifier of the association between CST IV-A and GBS RV+ status.

Keywords

cervicovaginal microbiota - dysbiosis - GBS - β-defensin-2 - microbiome - pregnancy

Publikationsverlauf

Eingereicht: 25. Oktober 2022

Angenommen: 05. Juli 2023

Artikel online veröffentlicht:
09. August 2023

• References

• 1 Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal Group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
• 2 McCoy JA, Elovitz MA, Alby K, Koelper NC, Nissim I, Levine LD. Association of obesity with maternal and cord blood penicillin levels in women with Group B Streptococcus colonization. Obstet Gynecol 2020; 136 (04) 756-764
• 3 Elovitz MA, Gajer P, Riis V. et al. Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. Nat Commun 2019; 10 (01) 1305
• 4 Gerson KD, McCarthy C, Elovitz MA, Ravel J, Sammel MD, Burris HH. Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix. Am J Obstet Gynecol 2020; 222 (05) 491.e1-491.e8
• 5 Gerson KD, McCarthy C, Ravel J, Elovitz MA, Burris HH. Effect of a nonoptimal cervicovaginal microbiota and psychosocial stress on recurrent spontaneous preterm birth. Am J Perinatol 2021; 38 (05) 407-413
• 6 Romero R, Hassan SS, Gajer P. et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2014; 2 (01) 4
• 7 Altoparlak U, Kadanali A, Kadanali S. Genital flora in pregnancy and its association with Group B streptococcal colonization. Int J Gynaecol Obstet 2004; 87 (03) 245-246
• 8 Brzychczy-Włoch M, Pabian W, Majewska E. et al. Dynamics of colonization with Group B streptococci in relation to normal flora in women during subsequent trimesters of pregnancy. New Microbiol 2014; 37 (03) 307-319 (In eng)
• 9 Rick AM, Aguilar A, Cortes R. et al. Group B streptococci colonization in pregnant Guatemalan women: prevalence, risk factors, and vaginal microbiome. Open Forum Infect Dis 2017; 4 (01) ofx020
• 10 Ravel J, Gajer P, Abdo Z. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011; 108 (suppl 1, suppl 1): 4680-4687
• 11 Starc M, Lučovnik M, Eržen Vrlič P, Jeverica S. Protective effect of Lactobacillus crispatus against vaginal colonization with Group B streptococci in the third trimester of pregnancy. Pathogens 2022; 11 (09) 980
• 12 Noda-Nicolau NM, Silva MC, Bento GFC. et al. Cervicovaginal levels of human beta defensins during bacterial vaginosis. PLoS One 2021; 16 (12) e0260753
• 13 Burris HH, Riis VM, Schmidt I, Gerson KD, Brown A, Elovitz MA. Maternal stress, low cervicovaginal β-defensin, and spontaneous preterm birth. Am J Obstet Gynecol MFM 2020; 2 (02) 100092
• 14 Fadrosh DW, Ma B, Gajer P. et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2014; 2 (01) 6
• 15 Liu CM, Aziz M, Kachur S. et al. BactQuant: an enhanced broad-coverage bacterial quantitative real-time PCR assay. BMC Microbiol 2012; 12: 56
• 16 Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011; 27 (21) 2957-2963
• 17 Kuczynski J, Stombaugh J, Walters WA, González A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Bioinformatics. 2011; ;Chapter 10:Unit 10.7. (In Eng).
• 18 R. E. UCHIME2: improved chimera prediction for amplicon sequencing. bioRxiv 2016
• 19 Cole JR, Wang Q, Fish JA. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 2014; 42 (Database issue): D633-D642
• 20 Liland KH, Vinje H, Snipen L. microclass: an R-package for 16S taxonomy classification. BMC Bioinformatics 2017; 18 (01) 172
• 21 Hug LA, Baker BJ, Anantharaman K. et al. A new view of the tree of life. Nat Microbiol 2016; 1: 16048
• 22 Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P. American Society for Microbiology provides 2020 guidelines for detection and identification of Group B Streptococcus . J Clin Microbiol 2020; 59 (01) e01230-20
• 23 DiGiulio DB, Callahan BJ, McMurdie PJ. et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A 2015; 112 (35) 11060-11065
• 24 De Gregorio PR, Juárez Tomás MS, Nader-Macías ME. Immunomodulation of Lactobacillus reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in a Murine Experimental Model. Am J Reprod Immunol 2016; 75 (01) 23-35
• 25 De Gregorio PR, Juárez Tomás MS, Leccese Terraf MC, Nader-Macías ME. Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model. J Appl Microbiol 2015; 118 (04) 1034-1047
• 26 Ortiz L, Ruiz F, Pascual L, Barberis L. Effect of two probiotic strains of Lactobacillus on in vitro adherence of Listeria monocytogenes, Streptococcus agalactiae, and Staphylococcus aureus to vaginal epithelial cells. Curr Microbiol 2014; 68 (06) 679-684
• 27 Rosen GH, Randis TM, Desai PV. et al. Group B Streptococcus and the vaginal microbiota. J Infect Dis 2017; 216 (06) 744-751
• 28 Fichorova RN, Morrison CS, Chen PL. et al. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. PLoS One 2020; 15 (01) e0224359
• 29 Brunner A, Medvecz M, Makra N. et al. Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus. Sci Rep 2021; 11 (01) 15999
• 30 Castro-Leyva V, Zaga-Clavellina V, Espejel-Nuñez A. et al. Decidualization mediated by steroid hormones modulates the innate immunity in response to Group B streptococcal infection in vitro. Gynecol Obstet Invest 2017; 82 (06) 592-600
• 31 Boldenow E, Hogan KA, Chames MC, Aronoff DM, Xi C, Loch-Caruso R. Role of cytokine signaling in Group B Streptococcus-stimulated expression of human beta defensin-2 in human extraplacental membranes. Am J Reprod Immunol 2015; 73 (03) 263-272
• 32 Prevention of Group B Streptococcal Early-Onset Disease in Newborns. ACOG Committee opinion, number 782. Obstet Gynecol 2019; 134 (01) 19-40